International journal of molecular sciences

Mitochondrial Quality Control in Neurodegeneration and Cancer: Shared Features and Unique Treatment Challenges

Updated

Abstract

Essence

links neurodegeneration and cancer but creates disease-specific therapeutic dilemmas.

Evidence

This review synthesizes mechanistic evidence on MQC pathways in neurons and cancer cells, especially and .

Caveat

Translation is difficult because the same MQC pathways can have opposite, context-dependent effects across the two disease settings.

Simplified

Full Text

What this is

  • () mechanisms are vital for cellular health, influencing both neurodegeneration and cancer.
  • Dysregulation of leads to distinct outcomes in these diseases, with neurons suffering from mitochondrial dysfunction while cancer cells adapt to survive.
  • This review explores the roles of () and , highlighting their context-dependent effects.
  • Understanding these mechanisms may inform therapeutic strategies for conditions that share mitochondrial defects.

Essence

  • mechanisms, including and , are crucial in both neurodegeneration and cancer, but their roles differ significantly. In neurodegeneration, these pathways can become harmful when overstimulated, while in cancer, they may promote survival and resistance to therapy.

Key takeaways

  • Mitochondrial dysfunction contributes to neurodegenerative diseases by impairing energy production and increasing oxidative stress. This dysfunction is linked to the accumulation of misfolded proteins and neuronal cell death.
  • In cancer, mechanisms are often co-opted to enhance tumor survival and proliferation. Elevated expression of markers correlates with worse clinical outcomes in cancer patients.
  • The dual nature of mechanisms necessitates careful consideration in therapeutic approaches, as enhancing these pathways may benefit neurodegeneration but worsen cancer outcomes.

Caveats

  • The roles of and are not consistent across different studies and disease models, complicating the understanding of their effects.
  • Most findings are based on rodent models or cultured cells, which may not fully replicate human disease complexity.
  • There is a lack of reliable biomarkers to monitor activity in patients, hindering clinical translation.

Definitions

  • Mitochondrial Quality Control (MQC): A set of mechanisms that maintain mitochondrial function, including proteostasis, mitophagy, and mitochondrial biogenesis.
  • Mitochondrial Unfolded Protein Response (mtUPR): A stress response pathway activated by misfolded proteins in mitochondria, aimed at restoring proteostasis.
  • Mitophagy: A selective autophagic process that removes damaged mitochondria to maintain cellular health.

Simplified

Funding

Competing interests

0 of 4
authors report competing interests
4 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free